Literature DB >> 3202190

Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport.

B A Stanton1, B Kaissling.   

Abstract

This study was conducted to determine whether a chronic increase in sodium delivery to, and sodium uptake by, the distal tubule stimulates the transport capacity of this tubular segment. To increase the rate of sodium delivery to the distal tubule, furosemide (12 mg/day) was administered continuously to rats by osmotic minipump for 6 days. Volume depletion was prevented by giving the animals a drinking solution containing 0.8% NaCl and 0.1% KCl. Control animals were given vehicle (0.9% NaCl) by osmotic minipump and tap water to drink. All animals were adrenalectomized and given replacement doses of aldosterone (0.5 microgram.100 g-1.day-1) and dexamethasone (1.2 microgram.100 g-1.day-1) to eliminate changes in adrenal corticosteroid levels. Furosemide was withdrawn 12 h before sodium and potassium transport rates were measured in distal tubules by in vivo microperfusion. We found that increased sodium uptake dramatically enhanced the transport capacity of the distal tubule. Sodium absorption rose from 71.7 to 316.7 pmol.min-1.mm-1, and potassium secretion increased from 30.7 to 73.7 pmol.min-1.mm-1. This response was accompanied by an increase in cell and mitochondrial volume and by proliferation of the basolateral membrane of distal convoluted cells, connecting tubule cells, and principal cells in the distal tubule. We conclude that a chronic increase in sodium uptake by the distal tubule, independent of alterations in extracellular fluid volume and aldosterone levels, stimulates the transport capacity of this nephron segment in part by inducing specific alterations in cell ultrastructure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202190     DOI: 10.1152/ajprenal.1988.255.6.F1269

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  34 in total

1.  Effect of high NaCl intake on Na+ and K+ transport in the rabbit distal convoluted tubule.

Authors:  T Shimizu; K Yoshitomi; J Taniguchi; M Imai
Journal:  Pflugers Arch       Date:  1989-09       Impact factor: 3.657

Review 2.  BK channels and a new form of hypertension.

Authors:  P Richard Grimm; Steven C Sansom
Journal:  Kidney Int       Date:  2010-08-18       Impact factor: 10.612

Review 3.  Oral sodium and potassium binders in heart failure.

Authors:  Alanna A Morris; Robert T Cole; Javed Butler; Divya Gupta
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 4.  Distal convoluted tubule.

Authors:  James A McCormick; David H Ellison
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

Review 5.  Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.

Authors:  D A Sica; T W Gehr
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

6.  Hypertrophy in the Distal Convoluted Tubule of an 11β-Hydroxysteroid Dehydrogenase Type 2 Knockout Model.

Authors:  Robert W Hunter; Jessica R Ivy; Peter W Flatman; Christopher J Kenyon; Eilidh Craigie; Linda J Mullins; Matthew A Bailey; John J Mullins
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

Review 7.  Loop diuretic resistance complicating acute heart failure.

Authors:  Zachary L Cox; Jeffrey M Testani
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 8.  A perspective on diuretic resistance in chronic congestive heart failure.

Authors:  Niel Shah; Raef Madanieh; Mehmet Alkan; Muhammad U Dogar; Constantine E Kosmas; Timothy J Vittorio
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-07-20

Review 9.  Causes and treatment of oedema in patients with heart failure.

Authors:  Andrew L Clark; John G F Cleland
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

Review 10.  Mechanisms and management of diuretic resistance in congestive heart failure.

Authors:  L K M De Bruyne
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.